Metformin Hydrochloride Extended Release 1000 mg Tablets: Gliempaflozin Tablet.

Extended Release Metformin Hydrochloride 1000 mg tablets are commonly prescribed for managing type 2 diabetes mellitus. Manufactured by Steris Pharma Pvt Ltd, these tablets effectively regulate blood sugar levels. This article provides an in-depth overview of Extended Release Metformin Hydrochloride, including its formulations, benefits, and combination therapies.

What is Extended Release Metformin Hydrochloride?

Extended Release (ER) Metformin Hydrochloride is designed to release the medication gradually, ensuring prolonged therapeutic effects with fewer side effects. It helps in:

• Enhancing insulin sensitivity

• Reducing hepatic glucose production

• Improving glucose uptake in muscles

Unlike immediate-release formulations, ER Metformin is taken once daily, improving patient compliance and minimizing gastrointestinal discomfort.

Metformin Hydrochloride Tablets IP

Manufactured in compliance with Indian Pharmacopoeia (IP) standards, Metformin Hydrochloride Tablets IP ensure high quality and efficacy. They are prescribed as monotherapy or in combination with other antidiabetic medications to effectively manage blood sugar levels.

Benefits of Metformin Hydrochloride Tablets IP

• Effectively controls high blood sugar levels

• Aids in weight management for diabetic patients

• Lowers the risk of cardiovascular complications

• Minimizes the risk of hypoglycemia when used alone

Metformin Hydrochloride Prolonged Release 1000 mg

Metformin Hydrochloride Prolonged Release 1000 mg is an advanced formulation that provides a steady release of the drug over an extended period. This enhances tolerance and improves effectiveness in managing type 2 diabetes.

Advantages of Prolonged Release Formulations

• Fewer gastrointestinal side effects

• More stable blood glucose levels throughout the day

• Improved adherence due to reduced dosing frequency

Metformin Hydrochloride Prolonged Release Tablets

These tablets ensure a controlled and sustained release of metformin, preventing fluctuations in glucose levels. They are particularly beneficial for patients who experience stomach discomfort with immediate-release formulations.

Combination Therapies

Gliclazide and Metformin Hydrochloride Tablets

This combination brings together two potent antidiabetic agents:

• Metformin Hydrochloride – Lowers hepatic glucose production

• Gliclazide – A sulfonylurea that stimulates insulin release from the pancreas

Benefits of Gliclazide and Metformin Hydrochloride Tablets

• Enhances insulin secretion

• Controls fasting and postprandial blood sugar levels

• Reduces the risk of diabetes-related complications

Glimepiride and Metformin Hydrochloride Tablets

Another effective combination therapy, these tablets help manage type 2 diabetes through dual mechanisms.

Benefits of Glimepiride and Metformin Hydrochloride Tablets

• Glimepiride – Stimulates insulin release and enhances peripheral glucose utilization

• Metformin Hydrochloride – Reduces hepatic glucose production

• Together, they offer superior glycemic control compared to monotherapy

Vildagliptin and Metformin Hydrochloride Tablets

Vildagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucagon levels, complementing the effects of metformin.

Uses of Vildagliptin and Metformin Hydrochloride Tablets

• Enhances glucose-dependent insulin secretion

• Lowers excess glucagon levels in fasting and postprandial states

• Provides better blood sugar control compared to monotherapy

Why Choose Metformin Hydrochloride Tablets from Steris Pharma Pvt Ltd?

Steris Pharma Pvt Ltd is renowned for manufacturing high-quality Metformin Hydrochloride Tablets IP and combination therapies. Their formulations are:

• Clinically tested for safety and efficacy

• Produced under strict quality control measures

• Designed for optimal absorption and patient adherence

Why Steris Healthcare Is the Best Option For Metformin Hydrochloride Extended Release 1000 mg Tablet ?

Metformin Hydrochloride Extended Release 1000 mg Tablets are a key component in managing type 2 diabetes. The prolonged-release formulations and combination therapies with Gliclazide, Glimepiride, and Vildagliptin enhance glycemic control while minimizing side effects. With a commitment to high-quality standards, Steris Pharma Pvt Ltd remains a trusted choice for healthcare professionals worldwide.